Brandinium

Trademark search for:

NINLARO 1POINT

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2017-02-03 — Application filed
  • 2017-02-07 — Application filed
  • 2017-02-09 — Application filed
  • 2017-02-10 — Notice of design search code e-mailed
  • 2017-05-01 — Assigned to examiner
  • 2017-05-03 — Suspension letter written
  • 2017-05-03 — Letter of suspension e-mailed
  • 2017-05-03 — Notification of letter of suspension e-mailed
  • 2017-11-03 — Report completed suspension check case still suspended
  • 2018-05-03 — Report completed suspension check case still suspended
  • 2018-06-22 — Teas change of correspondence received
  • 2018-11-03 — Report completed suspension check case still suspended
  • 2019-05-04 — Report completed suspension check case still suspended
  • 2019-08-29 — Teas change of correspondence received
  • 2019-09-23 — Teas revoke/app/change addr of atty/dom rep received
  • 2019-09-23 — Attorney/dom.rep.revoked and/or appointed
  • 2019-11-22 — Assigned to lie
  • 2019-12-19 — Suspension checked - to attorney for action
  • 2019-12-26 — Assigned to examiner
  • 2020-01-06 — Application abandoned
  • 2020-01-07 — Application abandoned
  • 2020-01-07 — Application abandoned
  • 2020-01-07 — Final status recorded

Owner Information

Millennium Pharmaceuticals, Inc.
Cambridge , MA

Correspondent

Karl M. Zielaznicki, Esq. Troutman Sanders LLP
875 Third Avenue
c/o IP Services NYC
New York, NY 10022

Filing Details

Filing Date:
2017-02-03
Status Date:
2020-01-07
Filing Year:
2015

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.